Top Tweets for #EarlyDrugDevelopment
We're excited to welcome Pamela Munster as SCI's inaugural associate director for early detection & interception research. Her expertise in translational medicine, early-phase trials, & precision oncology will strengthen our #EarlyDrugDevelopment Program. https://t.co/3ab1ruC7KL
The super Teresa Profeta, research nurse 🏥 at @IEOufficiale
#earlydrugdevelopment program presenting today at #ESMO25 a nurse-led pivotal study on #financialtoxicity reported by patients enrolled in phase1 clinical trials in🇮🇹!
🔴 Too high, yet unaddressed!
#ESMOAmbassadors
Starting the @myESMO #advancedcourse in #earlydrugdevelopment in #hongkong with our #supermentor Prof @lillian_siu @AACRPres @pmcancercentre highlighting the successes and lessons learned from phase 1 trials.
Clinical research is key to advancing oncology care and requires strong regulatory knowledge and patient management skills. Join us virtually on May 14 for best practices in #ClinicalResearch and #EarlyDrugDevelopment—featuring a keynote from Jessica Steier, DrPH, PMP. Learn more: https://t.co/cxHS9vrbnF
Faculty will cover a range of topics, including:
— Scientific communication
— Ethical considerations and subject protection
— The lifecycle of translational and clinical research
— Recent advancements and FDA approvals
— Diversity in clinical trials with a focus on vulnerable populations
— Building community partnerships and referral networks
— The importance of collaborative, team-based care.
@MSKCancerCenter #MSKAPPCME
SCI member @ChrisChenMD reflects on his time as an FDA @AACR Oncology Educational Fellow and its impact on his career development. https://t.co/BGtRZVBmyJ #EarlyDrugDevelopment
Phase I #earlydrugdevelopment update from @AdventHealthCFL @AdventHealth #cancer Institute, Orlando #Florida - We continue to grow & coauthor or lead presentations at major conferences such as #ASCO & #ESMO - we are the largest program in central Florida & eager to expand our growing list of #pharma collaborators to offer multiple promising #cancer therapies to our highly diverse patient population in central Florida & beyond - please connect with me to discuss opportunities at #ESMO24 or message me!
#AACR24 American Association for Cancer Research conference April 5-10 https://t.co/1XWtBuMrO1 - Excited to attend and learn! Please 1) Look for updates from me, 2) Connect with me to collaborate with our rapidly growing Phase I program for #clinicaltrials #earlydrugdevelopment, and 3) see presentations I am honored to participate in from @AdventHealthCFL #cancer Institute, Orlando, #Florida - @OncoAlert @VivekSubbiah
🎉 Great news as our abstract has been accepted to #ASCO24☺️👏🏼
✔️ TTB as a tool to quantify #AEs in early clinical trials
🙏🏼Thanks to Dr. Rodon and @DavidHongMD for their support @MDAndersonNews
#earlydrugdevelopment #oncology
@VHIO
Phase I #clinicaltrial #earlydrugdevelopment update from @AdventHealthCFL #cancer institute, #Orlando/Celebration #Florida -Our rapidly growing Phase I Clinical Research Unit offers new cutting-edge #cancer therapies to the highly diverse and expanding community of central Florida & beyond-Delighted to offer several promising novel agents from our expanding pipeline of trials #immunotherapy #targetedtherapy #antibodydrugconjugates to treat advanced #cancer-please contact us for more information or to participate -#clinicaltrial participation is critically important to make advances! @FLASCO_ORG
ESMO Advanced Course on Early Drug Development in Hong Kong was an incredible experience - @babak_phd
@myESMO
#Cancer #EarlyDrugDevelopment #ESMO #EuropeanSocietyForMedicalOncology #OncoDaily #Oncology
https://t.co/FcrWMUjBrc
Join us at the Stanford Cancer Institute! We're seeking applicants for an #AssistantProfessor role in our #EarlyDrugDevelopment Program. Learn more, apply, and share widely: https://t.co/7lnED2yEbZ #hiringnow
Phase I #clinicaltrial #earlydrugdevelopment update from @AdventHealthCFL #cancer institute, #Orlando #Florida -Our Phase I Research Unit is growing rapidly to offer new #cancer therapies to the highly diverse and expanding community of central Florida-Delighted to offer several promising novel agents including the following and many-many more: 1) STAR-0602 @MarengoTx: bifunctional antibody binding Vβ6/Vβ10 T cell receptors fused to IL-2 to promote activation & expansion of T cells, 2) IMP1734 @EikonTX: selective PARP1 inhibitor that may offer a better therapeutic index than currently used PARP inhibitors for tumors with DNA repair genomic alterations, 3) KO-2806 @kuraoncology: next-generation farnesyl transferase inhibitor to treat advanced malignancies with RAS alterations, 4) IDE397 #IDEAYA Biosciences: MAT2A inhibitor for malignancies with MTAP gene deletions, 5) SRK181 @ScholarRock: monoclonal antibody to inhibits latent TGFβ1 & potentially overcome PD1 inhibitor resistance, 6) LOXO-435 @LoxoLillyOnc @EliLillyandCo: FGFR3-specific inhibitor with preserved potency against FGFR3 gatekeeper resistance mutants. Looking forward to our growing collaborations to offer new therapies to our diverse and growing community in central #Florida & beyond @FLASCO_ORG @BladderCancerUS https://t.co/Wo1dPa4pPW
#ASCO23 Look for the NECTA team out in force championing early phase in Aus #earlydrugdevelopment #clinicaltrials Our metro and regional sites always looking for new studies for #NSW #RAR We have experience in global #FIH and #CALD patients -potential partners, reach out to us!
#asco23-Looking to expand our growing list of #pharma collaborators to open first-in-human Phase I #earlydrugdevelopment #clinicaltrials-@AdventHealthCFL #cancer institute, #orlando #florida-Our population is characterized by #diversity & has unmet needs-Please check out our rapidly growing program-we offer exciting trials developing #immunotherapy #targetedtherapy #antibodydrugconjugates #precisiononcology - please contact me to discuss potential collaborations!
#earlydrugdevelopment-Expediting drug approval for #cancer by rethinking phase I trial designs (tumor-agnostic) and patient selection (patient-centric #PrecisionMedicine) is important-also need to 1) highlight trials as a standard of care, 2) provide easier path & incentives for physicians to refer for trials, 3) mechanism to pool data from Phase I trials to make advances in 'rare' cancer therapy @OncoAlert #AACR23
Researchers discuss efforts to speed drug approval process by rethinking phase I trials - AACR Annual Meeting News @AACR @OncoAlert #AACR23 https://t.co/T0GNaqUL5s
Always an honor and inspiring to meet a genius like @VivekSubbiah! Look forward to collaboration of our growing Phase 1 program @AdventHealthCFL #cancer institute in the rapidly growing diverse city of Orlando with @MDAndersonNews #Phase1 #earlydrugdevelopment #clinicaltrials @OncoAlert
#AACR23 - Looking to expand our growing list of #pharma collaborators in the exhibit halls to open first-in-human Phase I #earlydrugdevelopment #clinicaltrials @AdventHealthCFL #cancer institute, Orlando, Florida, USA! Please check out our program- we offer exciting trials developing #immunotherapy, #targetedtherapy #antibodydrugconjugates #precisiononcology and contact me to discuss potential collaborations!
Delighted to start work @AdventHealth Orlando #Florida to lead genitourinary oncology #bladdercancer #prostatecancer #kidneycancer #Phase1 #EarlyDrugDevelopment-honored to have many internationally recognized #cancer doctors as colleagues @OncoAlert @BladderCancerUS @FLASCO_ORG
There’s still time to register for the completely FREE virtual event of the year for @NCICTEP_ClinRes in #EarlyDrugDevelopment! The 2022 @theNCI Early Drug Development Meeting Registration is here! The morning session is amazing! https://t.co/FIaJmorzTb
@DrChoueiri @DrSapnaPatel @MyriamChalabi @myESMO @OncoAlert It was a very interesting session! If you missed it, Dr. Patel will be offering a reprise of the findings of @SWOG’s #S1801 on September 22, 2022 for the @NCICTEP_ClinRes #EarlyDrugDevelopment meeting, being held virtually. Agenda & registration is here: https://t.co/FIaJmor23D
Last Seen Hashtags on Sotwe
ensest
Seen from Turkey
rr34 yoruichi
Seen from United States
momson(***)***+filter:native_video
teenager
Seen from United States
cliphot
Seen from Vietnam
monkeyapp
Seen from Chile
献妈
Seen from United States
momson or #exny or #nolimit() +filter:native_video
Seen from Brazil
exny or #nolimit() +filter:native_video
Seen from United States
ometv
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.1M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.2M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.4M followers
KATY PERRY
@katyperry
88.7M followers
Taylor Swift
@taylorswift13
82.6M followers
Lady Gaga
@ladygaga
74.1M followers
Virat Kohli
@imvkohli
71.6M followers
Kim Kardashian
@kimkardashian
70.3M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.5M followers
Neymar Jr
@neymarjr
64.5M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.8M followers
X
@x
60.8M followers